Reportlinker.com

Reportlinker.com

June 25, 2008 15:04 ET

Examine the U.S. DNA-Based Diagnostic and Test Market

LONDON, UNITED KINGDOM--(Marketwire - June 25, 2008) - Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue.

U.S. DNA-Based Diagnostic and Test Market

http://www.reportlinker.com/p090376/US-DNA-Based-Diagnostic-and-Test-Market.html

DNA-based testing is moving into a new phase. Transformational technologies are allowing complex genetic (specific gene) and genomic (large numbers of genes) tests to move from research-only labs into medical and clinical labs that perform tests for individual patients to identify genes associated with specific medical conditions. Progress in this young industry is happening fast and furious. New discoveries about the genetic basis of disease are being made every day. And even though DNA-based tests have a relatively small impact on how medicine is practiced today, each new and encouraging development is a step closer to a day when healthcare can be tailored or personalized to an individual's genetic makeup.

This report examines the U.S. market for DNA-based test products that are commercially available today, or will be soon, to screen for disease, confirm a diagnosis in someone with disease symptoms or even determine if you carry a gene that predisposes you to disease - before it causes symptoms. Particular emphasis is given to adult genetic tests that predict risk of disease and predict the best treatment regimens for diagnosed disease.

Even as DNA-based diagnostic tests gain in popularity, matters of genetic privacy and ethics, as well as issues of reimbursement and regulation, are still being debated. The report also evaluates these potential obstacles to DNA-based tests becoming standard medical practice where they can be offered through a physician or directly to the public.


INTRODUCTION
Research Objectives and Targets
Research Methodology
SECTION A: MARKET CONDITION
1. Market Overview
1.1 Market History 

Table1-1: Important Industry Development

1.2 Market Structure and Character 

CLIA Regulations and Genetic Tests
"Two Path" System of FDA Regulation

1.3 Major Players and Character
1.4 Major Players' Products (Name, Targeted Diagnostic, Price, Product 
Feature) 

Comments/Notes

2. Market Trends (2006-2008)
2.1 Market Size (Total) 

Table2-1: DNA Test Makers, Product Revenues
Graph2-1: Market Size: DNA-based Diagnostics (All Product Segments)
Table2-2: Total U.S. Market Size: High and Low Estimates
Graph2-2: Total U.S. Market Size: High and Low Estimates

2.2 Market Size by Product Segment 

Diagnostic Testing Product Segments (DNA-Based Diagnostics)
Table2-3: Target, Healthy Adult (Pre-symptomatic), Potentially Sick 
Person (Prone to Disease), Sick Person (Diagnosed with Disease)
Table2-4: Surveyed Companies and Their Product Segment
Predisposition Tests and Primary Screening for Risk
Predictive Diagnostic Tests
Predictive Treatment Tests (Pharmacodiagnostics)
Prognosis Diagnosis (DNA-based Recurrence Risk Scores)
Table2-5: Market Size and Growth Rate, by Product Segment
Graph2-3: Market Size by Product Segment (10 Companies Surveyed)

3. Market Share by Product Segment 

Graph3-1: Market Share (%) 2006 and 2008

4. Distribution Structure
4.1 Basic Distribution Pattern
4.2 Sales (%) by Channel 

Graph4-1: Sales by Channel

4.3 Sales Agent Intervention and Influence 

Physician Customers
Laboratory Customers
Graph4-2: Laboratory Share (%) of DNA Testing in the U.S.
Clinical Labs as Distribution Partners

4.4 Distribution Character in B-to-C Business 

Who Buys a Do-It-Yourself DNA Test?
B-to-C Model Based on Genetic Counseling Services

5. New Product Development Trends
5.1 Development Trends by Product Segment 

Infectious Disease: Low-Cost, High-Volume Testing
Predictive Medicine: Primary Adult Screening and Secondary Prevention
Onco-Molecular: Testing for Human Cancers
Pharmacodiagnostics: Predicting Drug Response

5.2 Hot New Products (13 Products)
6. Technology Character in DNA Diagnostic Product Development
6.1 Trends of Development/Supported Technology
6.2 Development Speed and Improvement Points in the Above-Mentioned 
Technology 

Table6-1: Comparison of Faster (Ultrahigh-Throughput) Personal DNA 
Sequencers (Maker, Name of System, Process, Read length, Throughput, 
Machine Price, Est. Cost to Sequence One Person's Genome)

7. Future of Market
7.1 Market Potentiality 

Table7-1: Market Positioning 2010 to 2012
Graph7-1: Market Positioning 2010 to 2012
Developments and Drivers
Table7-2: Factors Affecting Market Expansion or Obstruction

8. Issues and Strategy for the DNA-Based Diagnostic and Test Business
8.1 Management of Individual Information (Privacy) 

Limited Federal Policy on Genetic Privacy
State Laws on "Genetic Exceptionalism"
Informed Consent
Laboratory Industry Best Practices

8.2 Organization of Ethics Committee, etc. 

Federal Oversight Agencies and Their Responsibilities
Medical Community Guidelines on Ethics
Corporate Ethics and Compliance Committees
Major Ethical Issues
Fairness, privacy in the use of genetic information
Clinical practice issues and evidence-based guidelines
Patents and commercialization of products
Ethics of consumer-directed marketing
Social issues

8.3 Current Status of DNA Counseling
8.4 Policy and Proposal by Insurance Industry 

Table8-1: Condition, Who's Covered, Approved Tests

SECTION B: 10 NOTABLE COMPANIES: ACTIVITIES & STRATEGIES
1-10 Notable Company (10 companies)
Common Research Items:
1) Company In-Brief (Name of Company, Revenue (Most recent data), 
Location, Established Year, Special Note)
2) Revenue by Business Segment
(DNA-based Diagnostic and Test, Drugs, Medical Equipments, etc.)
3) Revenue Forecast by Product: Type of DNA-based Diagnostic and Test 
(2006-2008
3)-1 Revenue Trends by Product Segment
3)-2 Most Important Product for Sales and Marketing Spending - and 
Key Reason for Spending on Product
4) Distribution Policy
4)-1 Basic Distribution Flow
4)-2 Status of Usage of Sales Agents, Wholesalers, etc.
5) R&D Activity
5)-1 Expenditure
5)-2 Most Important R&D Area for Capital Spending - and Key Reason 
for Spending
6) Technology Trends
6)-1 Technology Used in DNA-based Diagnostic and Test
6)-2 Patents Status
7) New Product Development Activity
7)-1 Product Character
7)-2 Product Development Areas where Company Invests More Money 
and Resources
8) Profitability
8)-1 Revenue Contribution of DNA-based Diagnostic and Test Business
8)-2 Profitability (%) of the Above-mentioned Business
9) Current Rules for the Business Operation
9)-1 Management of Privacy
9)-2 Company Policy on Ethics
9)-3 Status of Usage of DNA Counseling
10) Opinion - Future DNA Diagnostic and Test Market Outlook
10)-1 Product Segment where Company Can Expect Brighter Future
10)-2 Market Expansion and Obstruction Factors
(Positive Indications, Negative Indications)
10)-3 Business Potentiality of B-to-C Segment
APPENDIX B: Additional Companies Active in DNA-based Diagnostics 
and Personalized Medicine

To order this report:

U.S. DNA-Based Diagnostic and Test Market

http://www.reportlinker.com/p090376/US-DNA-Based-Diagnostic-and-Test-Market.html

More market research reports here!

Contact Information